USPTO serial 88354623
IMMODULON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 23, 2021
- Examiner
- MIZELLE HOWARD, DEZMONA JULYE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with IMMODULON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexandra MacKay
Alexandra MacKay STITES & HARBISON, PLLC401 COMMERCE STREETSUITE 800NASHVILLE, TN 37219Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information regarding immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of the research and development of immunotherapy products, namely, pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation | ACTIVE | — |
| 044 | Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Immodulon Therapeutics Limited
- Other trademarks owned by Immodulon Therapeutics Limited
- Other trademarks owned by Immodulon Therapeutics Limited
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IMMODULON
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 19, 2021 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Oct 19, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 5, 2021 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Oct 5, 2021 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| May 4, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 30, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 30, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 30, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 10, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 15, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 15, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 12, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 5, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 4, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 3, 2020 | DMCC | DATA MODIFICATION COMPLETED | — |
| Jul 30, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 5, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 6, 2019 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Dec 4, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 25, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 23, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 5, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 6, 2019 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| May 6, 2019 | ALIE | ASSIGNED TO LIE | — |
| Apr 27, 2019 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 11, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 28, 2019 | NWAP | NEW APPLICATION ENTERED | — |